Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
hV01 in Advanced Pancreatic Cancer
NCT07006077Phase 2Recruiting
- Sponsor
- Hangzhou ConVerd Co., Ltd.
- Start
- May 2025
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
A Phase 2 trial of CVD-1301.V01 in pancreatic cancer (PC), sponsored by Hangzhou ConVerd Co., Ltd.. Started May 2025; status: recruiting.
02
Drugs
CVD-1301.V01
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT07006077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07006077.